perfosfamide has been researched along with Contact Dermatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boerrigter, GH; Scheper, RJ | 1 |
| Boerrigter, GH; de Groot, J; Scheper, RJ | 1 |
2 other study(ies) available for perfosfamide and Contact Dermatitis
| Article | Year |
|---|---|
Local administration of cytostatic drug 4-hydroperoxy-cyclophosphamide (4-HPCY) facilitates cell-mediated immune reactions.
Topics: Adjuvants, Immunologic; Animals; Cyclophosphamide; Dermatitis, Contact; Dose-Response Relationship, Immunologic; Female; Guinea Pigs; Immune Tolerance; Immunity, Cellular; Injections, Intradermal; Time Factors | 1984 |
Intradermal administration of 4-hydroperoxy-cyclophosphamide during contact sensitization potentiates effector T cell responsiveness in draining lymph nodes.
Topics: Animals; B-Lymphocytes; Cyclophosphamide; Dermatitis, Contact; DNA Replication; Enzyme-Linked Immunosorbent Assay; Female; Guinea Pigs; Lymph Nodes; Lymphocyte Activation; T-Lymphocytes | 1986 |